Aneta Rogalska

21PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 27, 2026
Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?

|Mar 28, 2026
Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer.

Patrycja Gralewska-Zając, Aleksandra Przybylska, Marek Langner

|Jan 25, 2025
MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model.

Wiktoria Bębenek, Arkadiusz Gajek, Agnieszka Marczak

|Jan 25, 2025
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines.

Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek

|Nov 27, 2024
Folate Receptor Alpha-A Secret Weapon in Ovarian Cancer Treatment?

Karol Bukowski, Aneta Rogalska, Agnieszka Marczak

|Aug 10, 2024
Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer.

Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak

Pageof 4

Frequent Collaborators

13 joint publications

Agnieszka Marczak

8 joint publications

Arkadiusz Gajek

6 joint publications

Patrycja Gralewska-Zając

4 joint publications

Agnieszka Śliwińska